<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">scbmt</journal-id><journal-title-group><journal-title xml:lang="ru">БИОМЕДИЦИНА</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Biomed</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5982</issn><issn pub-type="epub">2713-0428</issn><publisher><publisher-name>Scientific center of biomedical technologies of Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">scbmt-45</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ДОКЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NON-CLINICAL RESEARCHES</subject></subj-group></article-categories><title-group><article-title>Влияние новой калиевой соли на основе 3-тиетанилзамещенного триазола на систему гемостаза</article-title><trans-title-group xml:lang="en"><trans-title>The study of new potassium salt based on 3-thietanil-substituted triazole in respect to hemostasis system</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самородов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Samorodov</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">avsamorodov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Камилов</surname><given-names>Ф. Х.</given-names></name><name name-style="western" xml:lang="en"><surname>Kamilov</surname><given-names>F. Kh.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Халимов</surname><given-names>А. Р.</given-names></name><name name-style="western" xml:lang="en"><surname>Khalimov</surname><given-names>A. R.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Клен</surname><given-names>Е. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Klen</surname><given-names>E. E.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Халиуллин</surname><given-names>Ф. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khaliullin</surname><given-names>F. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГБОУ ВПО «Башкирский государственный медицинский университет» Минздрава России</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2016</year></pub-date><pub-date pub-type="epub"><day>25</day><month>02</month><year>2019</year></pub-date><volume>0</volume><issue>3</issue><fpage>59</fpage><lpage>67</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Самородов А.В., Камилов Ф.Х., Халимов А.Р., Клен Е.Э., Халиуллин Ф.А., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Самородов А.В., Камилов Ф.Х., Халимов А.Р., Клен Е.Э., Халиуллин Ф.А.</copyright-holder><copyright-holder xml:lang="en">Samorodov A.V., Kamilov F.K., Khalimov A.R., Klen E.E., Khaliullin F.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.scbmt.ru/jour/article/view/45">https://journal.scbmt.ru/jour/article/view/45</self-uri><abstract><p>В данной работе представлены результаты исследования активности новой калиевой соли 2-[3-бром-1-(тиетанил-3)-1,2,4-триазолил-5-тио]уксусной кислоты в отношении системы гемостаза. Установлено, что калиевая соль 2-[3-бром-1-(тиетанил-3)-1,2,4-триазолил-5-тио]уксусной кислоты проявляет высокую антиагрегационную активность в условиях in vitro и in vivo и эффективность в качестве средства профилактики генерализованного тромбоза в эксперименте в сравнении с применяемыми в практике лекарственными средствами. Результаты проведенного исследования позволяют считать данное соединение перспективным антитромботическим средством.</p></abstract><trans-abstract xml:lang="en"><p>The paper shows preliminary preclinical findings of new potassium salt of 2-[3-bromine-1-(thietanil-3)-1,2,4-triazolil-5-thio]acetic acid in regards to hemostasis system. The research has determined that potassium salt of 2-[3-bromine-1-(thietanil-3)-1,2,4-triazolil-5-thio]acetic acid shows high antiaggregational activity under condition in vitro and in vivo , it is more efficient as means to experimentally prevent generalized thrombosis in comparison with the practically applied therapeutic agents. The findings allow to consider this compound a promising antithrombotic drug.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>производные 3-тиетанилзамещенного триазола</kwd><kwd>система гемостаза</kwd><kwd>антитромботическая активность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>3-thietanil-substituted triazole derivatives</kwd><kwd>hemostasis</kwd><kwd>antithrombotic activity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Клен Е.Э., Халиуллин Ф.А., Спасов А.А., Макарова Н.Н., Багаутдинова Л.Ф., Науменко Л.В. Синтез и гемореологические свойства новых производных 1,2,4-триазола // Хим.-фарм. журн. 2008. Т. 42. № 9. С. 15-17.</mixed-citation><mixed-citation xml:lang="en">Клен Е.Э., Халиуллин Ф.А., Спасов А.А., Макарова Н.Н., Багаутдинова Л.Ф., Науменко Л.В. Синтез и гемореологические свойства новых производных 1,2,4-триазола // Хим.-фарм. журн. 2008. Т. 42. № 9. С. 15-17.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по проведению доклинических исследований лекарственных средств. Ч. 1. - М.: Гриф и К. 2012. 944 с.</mixed-citation><mixed-citation xml:lang="en">Руководство по проведению доклинических исследований лекарственных средств. Ч. 1. - М.: Гриф и К. 2012. 944 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Badimon J.J., Lettino M., Toschi V. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: Effects of TFPI on plaque thrombogenicity under flow condition // Circulation. 1999. No. 14. P. 1780-1787.</mixed-citation><mixed-citation xml:lang="en">Badimon J.J., Lettino M., Toschi V. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: Effects of TFPI on plaque thrombogenicity under flow condition // Circulation. 1999. No. 14. P. 1780-1787.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Воrn G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal // Nature. 1962. Vоl. 194. Р. 927-929.</mixed-citation><mixed-citation xml:lang="en">Воrn G.V. Aggregation of blood platelets by adenosine diphosphate and its reversal // Nature. 1962. Vоl. 194. Р. 927-929.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">DiMinno G.S. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol / G.S. DiMinno // J. Pharmacol. exp. ther. 1983. Vol. 225. P. 57-60.</mixed-citation><mixed-citation xml:lang="en">DiMinno G.S. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol / G.S. DiMinno // J. Pharmacol. exp. ther. 1983. Vol. 225. P. 57-60.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Patrono C., Andreotti F., Arnesen H. Antiplatelet agents for the treatment and prevention of atherothrombosis // European Heart J. 2011. Vol. 32. P. 2922-2932.</mixed-citation><mixed-citation xml:lang="en">Patrono C., Andreotti F., Arnesen H. Antiplatelet agents for the treatment and prevention of atherothrombosis // European Heart J. 2011. Vol. 32. P. 2922-2932.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Samorodov A., Kamilov F., Timirkhanova G., Samorodova A., Khaliullin F., Murataev D. Antithrombotic activity of new 1-ethylxanthine cyclohexylammonium salt // FASEB J. 2014. No. 28. P. 1054-5.</mixed-citation><mixed-citation xml:lang="en">Samorodov A., Kamilov F., Timirkhanova G., Samorodova A., Khaliullin F., Murataev D. Antithrombotic activity of new 1-ethylxanthine cyclohexylammonium salt // FASEB J. 2014. No. 28. P. 1054-5.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
